Drug Identity
Active Ingredient
Pegfilgrastim
Drug Class
Immunostimulants
ATC Code
L03AA13
Status
Essential Medicine
How It Works
Rotate injection sites among thigh, abdomen (except for 2 inches around navel), buttocks and outer, upper arms, should not be administered in the period between 14 days before and 24 hours after administration of cytotoxic chemotherapy.
How to Take It
Dosage information not available for this product.
Safety Alerts
Hypersensitivity to E
coli derived proteins, secondary acute or chronic leukaemia, myelodysplastic syndrome
Important Warnings
Acute leukaemia, myelosuppressive chemotherapy, high dose chemotherapy, respiratory distress syndrome (discontinue) Monitor platelet count, haematocrit and for signs of splenic rupture, Sickle cell anaemia
Side Effects
Skeletaljoint and muscle paininj site painnon-cardiac chest painheadachesplenomegalyreversible elevated uric acidallergic reactions including anaphylaxiscapillary leak syndrome (including fatal cases). RareSplenic rupture
Drug Interactions
Antimetabolites.
Pregnancy & Lactation
Pregnancy
Risk cannot be ruled out, use only if extremely necessary.
Lactation
Contraindicated or not recommended.
Price Intelligence
Rs 63,028.52
DRAP approved maximum price · per unit · approved 23 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded
Should you consider an alternative?
Other options containing Pegfilgrastim, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
34
brands
46
molecules
1
alerts